What is the impact of chronic hypertension on placental development, fetal growth and maternal outcome in the stroke-prone spontaneously hypertensive rat (SHRSP)?
Introduction
Preeclampsia (PE) is one of the most serious hypertensive states of pregnancy, which can either manifest as a de novo syndrome in previously normotensive women, or as sudden worsening of a pre-existing (i.e. chronic) hypertensive condition progressing to superimposed PE (Roberts et al., 2013) . Diagnosis of PE in women suffering from chronic hypertension is challenging, but the condition is suspected when baseline hypertension (or normal blood pressure in cases of successful pharmacological management) rises after the 20th week and presents with increased or new onset proteinuria and/or signs of renal, hepatic and neurological disturbances or fetal growth restriction (FGR) (Sibai et al., 1998; Brown et al., 2001) . Pregnancies affected by chronic hypertension display a 3-fold increased risk of progressing to superimposed PE, which associates with higher maternal and fetal morbidity and mortality than all other forms of the syndrome (Roberts et al., 2013) . Currently affecting an estimated 5% of pregnant women worldwide, the prevalence of chronic hypertension is expected to increase owing to a global rise in obesity rates and childbearing age in fertile women, implying an increased risk of even more pregnancies being affected by PE in the future.
The placenta plays a critical role in the pathogenesis of PE, especially in the severe/early-onset forms of the syndrome. The initial insult occurs early at the placentation site with shallow endovascular trophoblast invasion and impaired remodeling of the maternal spiral arteries, which results in placental insufficiency caused by dysfunctional perfusion (Gilbert et al., 2008) . In turn, placental ischemia reperfusion injury, and oxidative and endoplasmic reticulum stress promote subsequent release of soluble mediators causing the exacerbated inflammatory response and systemic endothelial dysfunction (Redman et al., 2014) that ultimately account for the maternal syndrome (Redman and Sargent, 2010) . In contrast, despite the comparable presentation and outcomes with severe PE, the mechanisms implicated in the progression of chronic hypertension to superimposed PE are less clear. The nature of the factors promoting the sudden rise in blood pressure in pregnant hypertensive women who develop the condition is unknown, and current information on the impact of chronic hypertension on the placentation process is limited.
Animal models have greatly aided the understanding of disease mechanisms in gestational hypertensive disorders (Faas et al., 1995; Bohlender et al., 2000; Davisson et al., 2002; Maynard et al., 2003) . However, despite representing an increasingly relevant medical concern, basic research has largely neglected studies of pregnancies affected by pre-existing hypertension. In this context, we used the stroke-prone spontaneously hypertensive rat (SHRSP), a well-known cardiovascular disease model presenting severe hypertension and uterine vascular dysfunction (Okamoto and Aoki, 1963; Small et al., 2016) , to investigate whether the increased risk for superimposed PE affecting hypertensive pregnancies could be related to alterations in early events during the placentation process. Thus, we analyzed placental development, and maternal and fetal outcomes in SHRSP pregnancies and show that chronic hypertension interferes with the physiological remodeling of the spiral arteries, resulting in placental insufficiency and FGR and favoring the development of maternal symptoms consistent with PE.
Materials and Methods

Animals and experimental design
SHRSP and Wistar Kyoto (WKY) rats were purchased from Charles River Laboratories and maintained in the animal facility at Hospital Aleman. During the course of the experiments, animals were housed in individual cages at 21 ± 2°C and a 12:12-h light-dark cycle (7 AM-7 PM) with ad libitum access to standard commercial diet and water. Timed pregnancies were established by cohabitation of nulliparous females (8-12 weeks old, 200-250 g body weight) with congenic males, with detection of a vaginal plug as evidence of copulation, denoted as gestation day (GD) 1. A total of 37 WKY and 44 SHRSP breeding pairs were used, so that N = 5-7 pregnant animals per GD were included in the study. Breeding efficiency for each strain was measured as pregnancy rate, defined by averaging the percentage of pregnant animals (100 × N pregnant /N breeding pairs ) of every GD analyzed, as described previously (Krey et al., 2008) .
Ethical approval
All experiments were conducted according to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care Committee (CICUAL, School of Medicine, University of Buenos Aires).
Blood pressure determinations
Changes in blood pressure throughout pregnancy were evaluated by recording systolic blood pressure (SBP) and mean arterial pressure (MAP) values using a validated noninvasive volume pressure recording device, CODA 2 (Kent Scientific, Torrington, CT, USA) (Feng et al., 2008) . Measurements were obtained in conscious rats restrained in a thermal plastic chamber as described (Toblli et al., 2009) . To minimize the effects of distress during the measurements, all readings were carried out by the same operator and rats were trained for four weeks to become accustomed to restraint before inclusion in the study. In addition to pre-mating (baseline) records, determinations were made during the following critical periods of gestation (de Rijk et al., 2002) : GD1, GD7, GD9 (decidualization, preplacental period), GD13 (onset of trophoblast invasion), GD17 (late gestation, placental maturation) and GD19 (term gestation); and on postnatal day (PN) 4. All records were taken in the morning, with five cuff inflations as acclimation followed by 20 measurement cycles. The values were averaged, rare outliers (± 2 SD from mean) eliminated, and the SBP for each GD was expressed as the mean of the remaining measurements (from at least 10 remaining values/GD analyzed).
Biochemical analyses of renal function
Following blood pressure measurements, females were housed in individual metabolic cages with food and water ad libitum for collection of 24 h urine samples. Maternal body weight and urinary output were recorded, and urine samples were collected and stored at −20°C for subsequent analyses. Blood samples were collected from the abdominal aorta under anesthesia (thiopental sodium 40 mg/kg body weight, i.p.) prior to euthanizing for tissue collection. Aliquots of sera and urine were assayed for creatinine using the enzymatic ultraviolet method (Randox Laboratories, Crumlin, Ireland). Urinary protein content (24 h proteinuria) was determined by a standard turbidimetric assay and the creatinine clearance (CrCl) was calculated according to the standard formula as described previously (Toblli et al., 2009) .
Tissue collection
For collection of fetoplacental and renal specimens, rats were euthanized at GD14, GD18 or GD20 while under thiopental sodium anesthesia. The uterus was dissected exposing the fetoplacental units, and the number of viable and resorbed implantation sites was recorded for each uterine specimen. Whole implantation sites (i.e. the placenta with its associated mesometrial triangle and decidual tissue) were carefully separated and processed according to standard methods for histological sectioning (Geusens et al., 2010) . Kidneys were dissected, decapsulated and cut longitudinally, followed by fixation in phosphate-buffered 10% formaldehyde (pH 7.2) and paraffin embedding according to our standard protocol (Giani et al., 2011) .
Renal histology
Longitudinal sections (3 μm thick) of paraffin embedded organs were stained by the periodic acid Schiff (PAS), Masson trichrome and Sirius red methods and used for morphometric evaluation of renal damage. Histological evaluation of PAS and Masson staining was performed on 10-15 random fields photographed at ×600 magnification per section, using a Keyence BZ 9000 microscope. Stained sections were evaluated by two independent observers for the presence of structural alterations in glomerular size, mesangial matrix expansion and reduction of the urinary space as well as signs of fibrosis using Image J software (National Institutes of Health, https://imagej.nih.gov/) as described (Rangan and Tesch, 2007; Cotechini et al., 2014) . Briefly, images were converted to grayscale and glomerular area was estimated by encircling each glomerulus with an elliptical selection best fitting the parietal layer of Bowman's capsule, followed by empirical setting of threshold values appropriate for estimation of extracellular matrix content (PAS + area fraction), urinary space area (white pixel area fraction) and fibrosis (percentage Masson blue stained area fraction). The presence of capsular, perivascular and tubulointerstitial fibrotic lesions was confirmed on Picrosirius red stained sections evaluated under polarized light using a Nikon E400 microscope (Nikon Instrument Group, Melville, NY, USA).
Evaluation of fetal development
Morphometric analysis of fetal development was performed on GD18 and GD20. Briefly, uterine horns were cut longitudinally exposing the implantation units followed by dissection of the amnion to carefully separate the fetus and placenta, which were fixed overnight in Bouin solution. After clearing in 70% ethanol for one week, placental and fetal weights were recorded and fetal length (crown-rump) and head circumference measured using a Vernier caliper. Fetal maturation was assessed based on morphological criteria according to the Witschi developmental scale (Witschi, 1962) .
Placental histology and immunohistochemistry
Paraffin embedded implantation sites were sectioned (4 μm thick) parallel to the mesometrial-fetal axis, and stained following standard hematoxylineosin (HE), PAS and Masson trichrome protocols. For immunostaining, sections were deparaffinized and rehydrated, washed in PBS, and incubated in 3% H 2 O 2 in methanol for 30 min at room temperature for blocking endogenous peroxidase activity. After incubation with 2% normal serum for 20 min, polyclonal primary antibodies against perforin 1 (1:400, sc-374346, Santa Cruz Biotechnology, Dallas, TX, USA), alpha smooth muscle actin (1:1000, MU128-UC, Biogenex, Fremont, CA, USA), aldehyde dehydrogenase 1 A3 (Aldh1a3, 1:400; Abcam, Cambridge, UK) and Pan Cytokeratin (CK, 1:400, Z062201-2, Dako, Glostruck, Denmark) were added and slides incubated overnight at 4°C. The slides were then washed and incubated for 1 h at room temperature with a goat anti-rabbit PO-conjugated secondary antibody (1:200, Cat. #111-035-003, Jackson ImmunoResearch, West Grove, PA, USA), followed by signal detection using a liquid DAB+Substrate Chromogen System (cat. #K3467, Dako) at room temperature. After washing, nuclei were counterstained with 0.1% Mayer's hematoxylin, followed by a standard dehydration procedure and mounting in Vitro-Clud medium (R. Langenbrinck GmbH, Emmendingen, Germany). Isolectin B4 (IB4) binding was assessed as described previously (Freitag et al., 2014) .
Morphometric assessment of placental development and vascular remodeling
Placental structure was evaluated on HE stained sections using a method described for the mouse with slight modifications (Dokras et al., 2006) . All measurements were made on one set of 10 serial parallel sections taken through the center of the placental site (as indicated by the presence of a maternal spiral artery in the decidual layer) and perpendicular to its flat (fetal) side. The placental depth ratio was determined by drawing a line parallel to the base of the labyrinth, identifying the midpoint of this line, and then extending a perpendicular line (P) first to the outer edge of the junctional zone (identified by the presence of trophoblast giant cells), and then up to the peripheral edge of the mesometrial triangle (P+MT). The proportional depth occupied by the placental disc (Placental depth ratio, P: P+MT) was expressed as the ratio of the relative width of the labyrinth plus junctional zones (i.e. the first line, P) and the width of the whole implantation site (to the edge of the mesometrial triangle, P+MT). Then, the cross-sectional area occupied by the junctional zone (Jz ratio = Jz: Jz+L) was measured by manually tracing the junctional zone cell layer area (Jz, identified morphologically based on the presence of giant cells) and expressing it as a ratio of the area occupied by the non-decidual layers of the placenta (i.e. the placental disc, Jz+L). Analysis of vascularization of the labyrinth was performed on IB4 stained sections using Angiotool (Zudaire et al., 2011) , which allows automatic identification of vascular networks using multiscale Hessian analysis and skeletonization. For each section, 10 random fields were photographed at a ×200 magnification, which were then converted to inverse grayscale (dark background) images for the analysis. Masson trichrome staining was used to quantify the lumen sizes of the mesometrial triangle arteries. The outer diameter (OD) and luminal diameter (LD) of each vessel were traced at the point of the largest OD, and the LD:OD ratio was calculated to compare the proportionate luminal widths of the vessels in both mating models. Spiral artery remodeling was additionally assessed by counting the percentage of mesometrial triangle vessels with loss of immunoreactivity on alpha actin stained sections, as reported previously (Barrientos et al., 2013) . Tissue-(interstitial) and vascular-associated natural killer (NK) cells were quantified on perforin one stainings as described (Freitag et al., 2014) . For evaluation of interstitial and endovascular invasion we used the methods described by Vercruysse and coworkers with slight modifications (Caluwaerts et al., 2005; Vercruysse et al., 2006) . For each sample, the complete mesometrial triangle was photographed using the image stitching algorithm of the Keyence BZ 9000 analyzer. In the assembled images, the border of the mesometrial triangle was manually delineated and three concentric depth levels were defined by unilateral scaling of the contour to 2/3 and 1/3, respectively, as described previously (Geusens et al., 2008) . Individual photographs for each spiral artery (invaded and non-invaded) were copied out from the overview image and their position with respect to the depth levels was automatically recorded. On these images, endovascular invasion was determined by manually tracing a line covering the length of the pan cytokeratin (CK) + stretch within the arterial lumen using Image J, and referring it as a percentage of the total arterial contour. Interstitial invasion was measured by thresholding the CK + area fraction within the manually delineated mesometrial triangle set as the region of interest.
Statistical analyses
Data are expressed as mean ± SEM. Blood pressure profiles, biochemical markers of renal function and fetal development data were analyzed by two-way ANOVA with factors strain (WKY versus SHRSP) and GD and their interaction, followed by Bonferroni post-hoc tests. Percentages of Witschi stages and remodeled spiral arteries were evaluated by Fisher's exact test. Between-group differences were assessed by unpaired Student's t-tests, except for reproductive performance data, which were analyzed using the nonparametric Mann-Whitney test. All calculations were run using GraphPad Prism v 5.0 (GraphPad Software Inc, San Diego, CA, USA). A P value of less than 0.05 was considered statistically significant.
Results
SHRSP dams develop increased hypertension and pregnancy-specific renal damage towards term
Given the association of chronic hypertension with increased risk for development of superimposed PE, we first sought to investigate maternal outcomes in the SHRSP model. Figure 1A shows that the SHRSP had a poor reproductive performance compared to WKY, as noted by a reduction of the pregnancy rate and decreased number of implantation units per female. During SBP follow-up (pre-mating to postnatal day 4), we observed non-significant variations within normal values in WKY dams, with a slight progressive decrease during the last third of pregnancy (GD13 to GD19, Fig. 1B ). By contrast, SBP in SHRSP females was not only significantly higher than in WKY throughout gestation but rose steadily towards the last third of pregnancy. Indeed, the SHRSP showed a significant SBP increase versus baseline records at GD13 (P < 0.005 versus pre-mating and GD1) and GD17 (P < 0.05 versus GD1, Fig. 1B ) with the differences in the blood pressure profile compared to WKY being at their highest from GD9 to GD17 ( Supplementary Fig. S1A ).
To further define whether this significant elevation of baseline hypertension towards term could indicate a maternal superimposed PE syndrome in the SHRSP, sera and urine samples were analyzed for biochemical markers of renal function. Compared to WKY, basal albumin excretion (24 h proteinuria) and albumin-to-creatinine ratio in SHRSP dams were significantly increased (Fig. 1C ) on GD18. Analysis of the CrCl, however, showed no significant differences between models ( Supplementary Fig. S1B ). Notably, SHRSP dams presented a progressive decrease of the urinary output from GD18, which was statistically significant compared to WKY (Fig. 1D ) on GD20. Histological examination of kidney sections later in gestation showed significant alterations of glomerular morphology in the SHRSP; mainly characterized by mesangial extracellular matrix expansion (expressed as increased percentage PAS + area, Fig. 1E , Supplementary Fig. S1C) along with a significant increase in glomerular area ( Supplementary  Fig. S1C ). In addition, the proportion of renal fibrosis was greater in SHRSP in comparison to WKY, not only in glomeruli but also in medullary interstitium (Fig. 1E ). The kidneys of pregnant SHRSP presented capsular, perivascular and interstitial fibrotic lesions, as observed on Masson's trichrome (Fig. 1E ) and Sirius red staining (Fig. 1F) . Of note, kidney lesions in SHRSP dams were observed exclusively during pregnancy, as virgin WKY and SHRSP females (12 weeks old) showed no such lesions and their structural characteristics were similar to one another ( Supplementary Fig. S1D ).
SHRSP offspring show asymmetric growth restriction linked to placental insufficiency
Next, morphometric analyses were performed in order to assess the impact of hypertension on placental growth and its correlation with fetal outcomes. The progressive increase of placental weight towards GD20 observed in controls was abrogated in the SHRSP, as shown in Table I . Moreover, SHRSP showed a significant reduction of placental weight compared to WKY on GD20. SHRSP also displayed signs of placental insufficiency, indicated by a significant decrease in the fetal to placental weight ratio compared to WKY on GD20 (Table I ). The analyses further revealed that the SHRSP showed significant alterations in fetal growth and maturation compared to WKY. In particular, GD18 SHRSP fetuses were smaller and did not exhibit fusion of the eyelids and parallel digits, which are typical findings of Stage 33 of the Witschi developmental scale, as observed in WKY ( Fig. 2A) . Of note, SHRSP and WKY dams displayed similar maternal pregnancy weight profiles (Fig. 2B ). In addition, FGR in SHRSP pregnancies was evident as a significant reduction of fetal weight and size (Table I ) and a delayed maturation, with all GD18 SHRSP fetuses categorized as Witschi Stage 32 (Fig. 2C) . Furthermore, the cephalization index (head circumference/ body weight) was significantly increased in the SHRSP (2.14 ± 0.02 versus 2.40 ± 0.03, P < 0.001), indicating a 'brain-sparing' process consistent with asymmetric FGR. The differences persisted in the postnatal period, when SHRSP pup weight was significantly decreased compared to WKY (Table I) . In line with these findings, histological examination revealed marked structural alterations indicative of placental insufficiency in the SHRSP, which were evident as early as GD14. HE analysis of whole implantation site sections showed that the placental depth ratio, which represents the proportional depth occupied by the placental disc within the whole implantation site (Fig. 2D) , was significantly increased in the SHRSP on GD14 (Fig. 2E) . From GD14 to GD18, SHRSP placentas also showed an expansion of the labyrinth layer compared to the junctional zone (Jz, Fig. 2D insets, Fig. 2E ), which translated into a significant decrease of the Jz ratio compared to WKY (SHRSP 0.26 ± 0.01 . In all panels, *P < 0.05, **P < 0.01 and ***P < 0.001 as assessed by Mann-Whitney test (A) or two-way ANOVA and Bonferroni post-hoc comparison (B, C and D). Data shown are mean values ± SEM derived from five to seven rats per group each analyzed in duplicate.
versus WKY 0.47 ± 0.02, P < 0.001). PAS staining further revealed that the decreased fractional area of the junctional zone layer was associated with a significant depletion of glycogen cells in GD14 SHRSP placentas, which was confirmed as reduced expression of the glycogen trophoblast marker Aldh1a3 (Fig. 3A) . Isolectin B4 (IB4) staining to highlight the fetal vasculature of the labyrinth at GD18 revealed substantial differences between the two models, as WKY placentas showed an elongated, highly branched and less heterogeneous vascular network compared to SHRSP (Fig. 3B) . Specifically, quantitative analysis demonstrated a significant reduction in the vascular surface area, vascular density and branching index, and a significant increase in lacunarity (Fig. 3C ) in SHRSP placentas.
Chronic hypertension interferes with spiral artery remodeling and trophoblast invasion in SHRSP pregnancies
Results for the analysis of vascular remodeling and trophoblast invasion in the placental bed are summarized in Fig. 4 . On GD14, the spiral arteries in the mesometrial triangle region of SHRSP placentas had thickened walls compared to WKY, and retained the actin coat in the media (Fig. 4A) . Impaired vascular remodeling in the SHRSP was evident both as a significant reduction of the arterial lumen (denoted as LD:OD ratio, Fig. 4B ) and a significantly decreased percentage of vessels with loss of actin reactivity (Fig. 4B ) compared to WKY. Additionally, SHRSP placentas displayed a significant reduction in the density of PRF1 + NK cells infiltrating interstitial (tissue-associated) and perivascular regions of the mesometrial triangle ( Fig. 4A and C) . Cytokeratin staining of GD18 implantation sites further revealed that the extent of interstitial trophoblast invasion into the mesometrial triangle (measured as percentage CK + area, Fig. 4D and E) was significantly increased in SHRSP placentas (Fig. 4E) . However, when analyzing the extent of CK staining within the arterial contour (Fig. 4E) , SHRSP placentas displayed a defective endovascular invasion compared to WKY. These differences were not evident on arteries located in the deeper region adjacent to the placenta (Zone 1, Fig. 4D ), which showed a similar content of endovascular trophoblast with mainly intraluminal and intramural location. In contrast, arteries on the central and outer region approaching the mesometrium displayed mostly an intramural pattern of invasion, with a significantly decreased percentage of endovascular trophoblast in SHRSP placentas (Fig. 4E ).
Discussion
The three main aspects involved in the pathogenesis of PE are changes in the behavior of fetal trophoblast cells, their interactions with maternal endothelium and the maternal system's response to these vascular changes. Here, we investigated maternal and fetoplacental aspects influencing pregnancy outcome in the SHRSP strain and introduce a novel model that mimics several of the features observed in hypertensive patients who develop superimposed PE, including the diagnostic criteria of elevated baseline hypertension with compromised renal function (Roberts et al., 2013) . Our analysis further revealed that such a maternal response occurred secondary to an abnormal interaction between trophoblasts and the maternal vasculature during placentation, providing new insights about the mechanisms by which preexisting hypertension may contribute as a risk factor for development of superimposed PE during gestation. During pregnancy, the SHRSP not only conserved the hypertensive phenotype typical of the strain but showed a progressive worsening towards term with a significant SBP increase with respect to baseline (pre-mating) on GD13. Although with some inconsistencies (probably related to different experimental designs), previous studies have reported a similar profile in pregnant SHRSP including a significant increment of SBP from GD7 to GD12 compared to pre-pregnancy values (Shibukawa et al., 1990) , and a greater increase versus the values observed in WKY between GD10 and GD14 (Small et al., 2016) . Furthermore, our analyses verified the marked blood pressure drop previously described in pregnant SHRSP prior to delivery, which has been attributed to a physiological response involving vascular wall nitric oxide synthase (NOS3) upregulation (Gompf et al., 2002) . Previous analyses have shown that blood pressure elevation in the SHRSP strain was a spontaneous, pregnancy-specific effect further enhanced by NaCl administration and speculated that salt-loaded SHRSP may be a useful model for toxemia of pregnancy/PE (Shibukawa et al., 1990) . By demonstrating a significant impact of blood pressure changes on maternal renal function, the results of the current study support this view and provide stronger evidence for pregnant SHRSP per se constituting a model for the pathophysiology of PE superimposed on chronic hypertension. Interestingly, SHRSP showed increased urinary protein excretion compared to WKY at term, in line with previous findings reporting a steady increase in the albumin-to-creatinine ratio over the course of pregnancy (Small et al., 2016) . Even though protein levels observed in both studies remained within the physiological range, the morphological changes observed in SHRSP kidneys indicate that increased urinary protein excretion in this strain is indeed a sign of underlying maternal renal dysfunction. Of note, pathological changes in SHRSP kidneys were not only confined to the glomeruli, which showed mesangial expansion and other modifications consistent with endotheliosis, but also included the renal vasculature and juxtamedullary interstitium. Although further studies are needed to confirm this hypothesis, the extent of renal damage observed in the SHRSP may be associated with alterations in the tubulointerstitial compartment as noted by the progression to reduced urine output towards term. Indeed, low urine output is a relatively frequent complication of PE that when diagnosed, warrants classification of the disease as 'severe', mandating immediate intervention (Clark et al., 1986) . Besides affecting maternal outcome, chronic hypertension in the SHRSP had a significant impact on fetal development as evidenced by the maturation delay and decreased weights in the offspring. FGR, clinically defined as a failure to achieve the endorsed growth potential based on differences compared to an estimate fetal weight threshold (Figueras and Gratacos, 2014) , can develop as a result of fetal, maternal or placental factors. The growth restriction features observed in the SHRSP were similar to those reported in the parentally related Spontaneously Hypertensive Rat (SHR) strain, which has been characterized as an animal model of asymmetric FGR (Bassan et al., 2005) . This pattern, which corresponds to the vast majority of FGR cases, results from an inadequate transfer of nutrients owing to an adverse uterine environment and placental dysfunction, and thus shows a strong association with PE (Cox and Marton, 2009; Figueras and Gratacos, 2014) . Accordingly, SHRSP females showed a significant reduction of both placental mass and the fetal to placental ratio compared to WKY, which is consistent with observations in pregnancies affected by severe PE and FGR (McMaster et al., 2004) . The fetal to placental ratio, in particular, is considered a proxy measure that reflects how efficiently placental development and function accommodate to meet the nutritional demands of the growing fetus (Hayward et al., 2016) . Reduction of the fetal to placental ratio implies a failed placental adaptation of nutrient supply, which is consistent with our finding that morphological defects in SHRSP placentas were mostly restricted to the labyrinth where metabolic exchange between the maternal and fetal circulations takes place, and also with previous reports showing decreased Na . In all panels *P < 0.05, **P < 0.01 and ***P < 0.001 as assessed by two-way ANOVA or unpaired Student's t-tests. Data shown are mean values ± SEM derived from five to seven rats per group each analyzed in duplicate.
associated with active transport of amino acids in the SHRSP placenta (Fuchi et al., 1995) . Thus, the decreased vascular density and branching index observed in SHRSP pregnancies may result in a decreased surface area for metabolic exchange caused by defective capillary expansion in the fetal compartment (Mayhew et al., 2004) , consistent with the differences in villous development and patterns of capillary branching observed in pregnancies complicated with PE and FGR. Of note, recent studies have reported an increased expression of hypoxia-related markers in the labyrinth in connection with an impaired development of the junctional zone layer in the GD18 SHRSP placenta (Small et al., 2016) . Here, we confirmed these results by showing a significant depletion of glycogen cells with reduced expression of the retinoic acid synthetizing enzyme Aldh1a3 from the SHRSP placenta, occurring as early as GD14. Though this possibility warrants further investigation, these results together suggest that placental insufficiency may result from an underlying alteration of trophoblast lineage differentiation related to an increase in oxidative stress or hypoxia in the SHRSP placenta. The SHRSP model also reproduced one of the defining features of the early-onset type of PE, which is the incomplete remodeling of uterine spiral arteries preceding the onset of the maternal syndrome (Redman, 2011) . Recent studies have shown that the normal arterial functional response to pregnancy (i.e. outward hypertrophic remodeling, increased arterial distensibility and endothelium-dependent relaxation) is blunted in the SHRSP, representing a spontaneous model of deficient uteroplacental vascular remodeling (Small et al., 2016) . However, these authors focused on the remodeling of larger, more upstream (i.e. preplacental) vessels; which is secondary to the physiological changes of trophoblast-dependent remodeling of the spiral arteries within the placental bed (Osol and Mandala, 2009 ) that were analyzed in the present study. In humans, this initial process can be further divided into three stages according to structural criteria: trophoblast invasion-independent vascular changes; remodeling induced by perivascular interstitial trophoblast; and trophoblast infiltration of vessel walls (Kaufmann et al., 2003) . In the rat, the first stage is also known as the 'first wave' of spiral artery remodeling and involves a generalized perturbation of vessel structure, disorganization of mural smooth muscle and lumen dilation, which are primarily guided by the specialized leukocyte subset uterine NK cells (Soares et al., 2012) . Later on, a 'second wave' of arterial remodeling analogous to human Stages 2 and 3 involves further structural modifications mediated by trophoblasts committed along two different invasion pathways (interstitial or endovascular), the interrelation of which remains to be clearly established (Caluwaerts et al., 2005 , Vercruysse et al., 2006 . Alterations in both waves of spiral artery remodeling were evident in the SHRSP; as noted first by the luminal narrowing and increased smooth muscle content together with decreased densities of PRF1-expressing NK cells on GD14, and by the more pronounced decrease in the extent of trophoblast infiltration of the arterial contour observed in outer regions of the mesometrial triangle on GD18. A striking finding was, however, the increased percentual area of CK staining within the mesometrial triangle of SHRSP placentas, which represents an enhanced interstitial invasion in this model. This may be explained by an adaptation response favoring structural changes mediated by perivascular interstitial trophoblasts in order to compensate for underlying defects in the endovascular differentiation route. Impaired endovascular differentiation, in turn, could arise as a consequence of events during the first wave of remodeling, as rat NK cells have been demonstrated to modulate the acquisition of a pseudo-endothelial phenotype by endovascular trophoblasts (Chakraborty et al., 2011) . Indeed, it is conceivable that subtle alterations in a delicate interplay between NK cell actions and changes mediated by both interstitial and endovascular trophoblast cells may account for contrasting findings in the vascular remodeling process reported in other studies, such as the increased mural smooth muscle content despite deeper endovascular invasion observed in the reninangiotensin based transgenic rat model of PE (Geusens et al., 2010) . As previously stated by Kaufmann and coworkers, these observations challenge the concept of 'shallow trophoblast invasion' as the sole placental cause of PE, which should rather be considered the consequence of maladaptation of placental bed arteries resulting both from intrinsic factors related to trophoblast cell behavior and extrinsic factors operating in the maternal compartment (Kaufmann et al., 2003) . On the one hand, since in rodents Aldh1a3-expressing trophoblasts represent the first stream invading the decidua and maternal vessels (Coan et al., 2006; Outhwaite et al., 2015) , the defective development of the junctional zone layer with reduced glycogen cell content observed in SHRSP placentas may directly impact the remodeling of spiral arteries in this model. However, the finding that SHRSP also exhibit a certain degree of uterine vascular dysfunction in the non-pregnant state (Small et al., 2016) alternatively suggests that the primary insult underlying defective arterial remodeling in pregnancies affected by chronic hypertension could result from an abnormal vascular substrate that fails on its interactions with invasive trophoblast cells. Traditional maternal risk factors for PE (such as obesity and chronic hypertension) may exert their effect by inducing alterations in the endometrial lining towards a more inflammatory milieu and a preset endothelial activation; which would in turn affect trophoblast mass, spiral artery plugging and endovascular invasion with consequent impact on spiral artery remodeling. We suggest that our model is particularly useful to explore the relative contribution of defects in the trophoblast differentiation program versus maternal endothelium anomalies underlying the reduced spiral artery endovascular invasion associated with PE and chronic hypertensive pregnancies. The extensive characterization of maternal, fetal and placental determinants of pregnancy outcome in the SHRSP provided in the present study argues in favor of introducing a novel experimental model that recapitulates many of the features associated with PE superimposed on chronic hypertension: a clinical entity that has been neglected in basic research on hypertensive disorders of pregnancy. Of the very few animal models for chronic hypertensive pregnancies introduced so far (Davisson et al., 2002; Gillis et al., 2015) , the SHRSP presents the additional advantage of allowing comparative analyses with normotensive controls but also with the parental SHR strain, which exhibits a normal pregnancy outcome despite their hypertensive condition (Peracoli et al., 2001) . Such studies would have important implications towards defining the nature of the factors that determine that only a subset of pregnant hypertensive women develop superimposed PE and whether it should be considered a separate clinical entity, different from 'de novo' PE. Future research in this model will not only impact on our understanding of the mechanisms underlying hypertensive disorders of pregnancy, but also shed light on their side effects and influence on diseases in later life.
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